Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 2, 2000, Pages 117-121

  Ibrahim, Nuhad K ^a   Valero, Vicente ^a   Theriault, Richard L ^a   Willey, Jie ^a   Walters, Ronald S ^a   Buzdar, Aman U ^a   Booser, Daniel J ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Continuous infusion; Metastatic breast cancer; Phase I study; Vinorelbine

Indexed keywords

DOXORUBICIN; NAVELBINE; PACLITAXEL;

ADULT; ARTICLE; BLOOD TOXICITY; BREAST CARCINOMA; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; FATIGUE; FEVER; GRANULOCYTOPENIA; HUMAN; LIFE EXPECTANCY; PHASE 1 CLINICAL TRIAL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; VINBLASTINE;

EID: 0033635823     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200004000-00003     Document Type: Article

References (23)

1. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast carcinoma
2. Phase II trial of weekly IV vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin American experience
3. Phase II trial with Navelbine in advanced breast cancer previously untreated
4. Phase II trial of Navelbine in advanced breast cancer
5. Phase II trial with Navelbine in advanced breast cancer
6. A phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy
7. Vinorelbine as first-line chemotherapy for metastatic breast cancer
8. Intravenous vinorelbine as first-line and second-line therapy in advanced breast carcinoma
9. Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer
10. Vinorelbine as second-line treatment in anthracycline pre-treated advanced breast cancer patients: A phase II study
11. Vinorelbine as a second-line treatment in anthracycline pre-treated advanced breast cancer patients
12. A phase II study of vinorelbine in patients with advanced breast cancer
13. Vinorelbine, a new active drug in breast carcinoma: Results of an ARTAC phase II trial
14. Weekly vinorelbine (Navelbine(R)) plus G-CSF in taxol-refractory metastatic breast cancer: A phase-II study
15. Activity of vinorelbine in advanced breast cancer: Preliminary results of a phase II trial
16. Vinorelbine is an active antiproliferative agent in pre-treated advanced breast cancer patients: A phase II study
17. Vinorelbine as single agent in pre-treated patients with advanced breast carcinoma
18. Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer
19. Weekly vinorelbine in previously treated patients with advanced breast cancer: Preliminary results
20. Five-day continuous infusion vinblastine in the treatment of breast cancer
21. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer
22. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine
23. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma